The lectins LABA (16,22) and PFA (23) used in the current work were discovered and GNA and NPL were characterized in our laboratory and were shown to possess an affinity toward altered, tumor-related glycoepitops, while NPL lectin was shown to be a promising marker of dying cells (24). This evidence concerns the gene NPL and neoplasm.